Platforms in Technology

Oryzon has a long tradition of integrating epigenetic technology platforms:

  • Genomics: including gene expression, copy number variation, and differential splicing analysis.
  • Bioinformatics: including mode of action studies.
  • Development of accompanying markers for in vivo efficacy studies.
  • Target validation.
  • Development of new biochemical or cellular assays including cell panel testing.
  • B2D2 Platform: including fragment-screening, crystallography and molecular modeling.

Our internal need for results of the highest quality for our programs in drug development is the best guarantee for the quality of our services.